BioMarin Pharmaceutical (BMRN) Revenue by Segment

History

Date	Voxzogo	Naglazyme	Palynziq	Brineura	Aldurazyme	Kuvan	Royalty and Other	Roctavian
Mar 31, 2026	932.27M	500.94M	429.50M	192.80M	196.18M	97.91M	49.12M	27.84M
Dec 31, 2025	926.39M	484.87M	432.94M	185.69M	208.44M	99.03M	53.49M	36.20M
Sep 30, 2025	861.39M	474.87M	407.94M	184.69M	198.44M	104.03M	49.93M	34.20M
Jun 30, 2025	833.19M	484.77M	389.54M	173.69M	215.44M	108.13M	46.51M	38.40M
Mar 31, 2025	795.70M	487.90M	371.90M	170.30M	197.60M	109.70M	43.98M	36.60M
Dec 31, 2024	734.60M	479.50M	354.60M	169.30M	183.90M	120.60M	44.48M	26.40M
Sep 30, 2024	672.30M	467.80M	342.40M	164.90M	187.60M	129.30M	45.90M	18.10M
Jun 30, 2024	605.50M	444.80M	330.70M	168.90M	130.40M	144.10M	47.10M	11.70M
Mar 31, 2024	534.90M	402.90M	317.30M	161.70M	132.10M	166.10M	47.80M	4.30M
Dec 31, 2023	469.80M	420.30M	304.00M	161.80M	131.20M	180.70M	46.80M	3.50M
Sep 30, 2023	390.90M	422.50M	288.50M	160.80M	126.20M	197.60M	45.70M	800.00K
Jun 30, 2023	316.20M	413.10M	275.80M	157.60M	141.40M	211.70M	44.60M	-
Mar 31, 2023	237.30M	438.80M	262.50M	157.20M	138.40M	218.70M	50.10M	-
Dec 31, 2022	169.20M	443.80M	255.00M	154.30M	128.40M	227.50M	53.90M	-
Sep 30, 2022	108.10M	426.40M	246.50M	149.10M	110.90M	242.40M	56.50M	-
Jun 30, 2022	59.90M	398.10M	241.00M	144.30M	106.30M	253.10M	59.40M	-
Mar 31, 2022	25.50M	401.10M	238.30M	136.90M	97.10M	274.30M	58.30M	-
Dec 31, 2021	5.80M	380.40M	237.40M	128.00M	122.70M	285.80M	62.80M	-
Sep 30, 2021	100.00K	417.00M	223.20M	125.60M	103.70M	306.40M	63.30M	-